Robert A Hauser

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Topics

Randomized Controlled Trial

Parkinson Disease

Top Venues

Movement disorders : official journal of the Movement Disorder Society

Journal of clinical psychopharmacology

Parkinson's disease

This page only lists publications with an associated author ORCID identifier.

Publications

Robert A Hauser, Hadas Barkay, Hubert H Fernandez, Joohi Jimenez-Shahed, Stewart A Factor, Nicholas Gross, Leslie Marinelli, Mark Forrest Gordon, Steve Barash, Stacy Finkbeiner, Nayla Chaijale, Karen E Anderson
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study. Journal of clinical psychopharmacology 44 (4) (2024)
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, Atul T Patel, Marta D Banach, Edvard Ehler, Domenico Vitarella, Roman G Rubio, Todd M Gross, null null
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology 102 (4) (2024)
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, Atul T Patel, Marta D Banach, Edvard Ehler, Domenico Vitarella, Roman G Rubio, Todd M Gross, null null
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology 102 (4) (2024)
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, Atul T Patel, Marta D Banach, Edvard Ehler, Domenico Vitarella, Roman G Rubio, Todd M Gross, null null
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology 102 (4) (2024)
Robert A Hauser, Hadas Barkay, Hubert H Fernandez, Joohi Jimenez-Shahed, Stewart A Factor, Nicholas Gross, Leslie Marinelli, Mark Forrest Gordon, Steve Barash, Stacy Finkbeiner, Nayla Chaijale, Karen E Anderson
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study. Journal of clinical psychopharmacology (2024)
Robert A Hauser, Hadas Barkay, Hubert H Fernandez, Joohi Jimenez-Shahed, Stewart A Factor, Nicholas Gross, Leslie Marinelli, Mark Forrest Gordon, Steve Barash, Stacy Finkbeiner, Nayla Chaijale, Karen E Anderson
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study. Journal of clinical psychopharmacology 44 (4) (2024)
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, Atul T Patel, Marta D Banach, Edvard Ehler, Domenico Vitarella, Roman G Rubio, Todd M Gross, null null
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology 102 (4) (2024)
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, Atul T Patel, Marta D Banach, Edvard Ehler, Domenico Vitarella, Roman G Rubio, Todd M Gross, null null
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology 102 (4) (2024)
Stephen Aradi, Robert A Hauser
Current use of neurotoxins for alleviating symptoms of cervical dystonia. Expert review of neurotherapeutics 24 (8) (2024)
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, Atul T Patel, Marta D Banach, Edvard Ehler, Domenico Vitarella, Roman G Rubio, Todd M Gross, null null
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology 102 (4) (2024)
Robert A Hauser, Hadas Barkay, Hubert H Fernandez, Joohi Jimenez-Shahed, Stewart A Factor, Nicholas Gross, Leslie Marinelli, Mark Forrest Gordon, Steve Barash, Stacy Finkbeiner, Nayla Chaijale, Karen E Anderson
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study. Journal of clinical psychopharmacology 44 (4) (2024)
Davide Martino, Vikram Karnik, Roongroj Bhidayasiri, Deborah A Hall, Robert A Hauser, Antonella Macerollo, Tamara M Pringsheim, Daniel Truong, Stewart A Factor, Matej Skorvanek, Anette-Eleonore Schrag, null null
Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. Movement disorders : official journal of the Movement Disorder Society (2023)
Davide Martino, Vikram Karnik, Roongroj Bhidayasiri, Deborah A Hall, Robert A Hauser, Antonella Macerollo, Tamara M Pringsheim, Daniel Truong, Stewart A Factor, Matej Skorvanek, Anette-Eleonore Schrag, null null
Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. Movement disorders : official journal of the Movement Disorder Society (2023)
Alberto J Espay, Robert A Hauser, Rohit Dhall, Sandeep Thakkar, Leslie Cloud, Leonid Zeitlin, Ghazal Banisadr, Stanley Fisher, Hester Visser
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study. Movement disorders : official journal of the Movement Disorder Society 39 (2) (2023)
Alberto J Espay, Robert A Hauser, Rohit Dhall, Sandeep Thakkar, Leslie Cloud, Leonid Zeitlin, Ghazal Banisadr, Stanley Fisher, Hester Visser
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study. Movement disorders : official journal of the Movement Disorder Society 39 (2) (2023)
C Warren Olanow, Robert A Hauser, Daniel J Burdick, Rohit Dhall, Joy Antonelle de Marcaida, Ramon A Gil, David L Kreitzman, Lawrence W Elmer, Andrew McGarry, Karl Kieburtz, null null
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society (2023)
Alberto J Espay, Robert A Hauser, Rohit Dhall, Sandeep Thakkar, Leslie Cloud, Leonid Zeitlin, Ghazal Banisadr, Stanley Fisher, Hester Visser
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study. Movement disorders : official journal of the Movement Disorder Society 39 (2) (2023)
Alberto J Espay, Robert A Hauser, Rohit Dhall, Sandeep Thakkar, Leslie Cloud, Leonid Zeitlin, Ghazal Banisadr, Stanley Fisher, Hester Visser
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study. Movement disorders : official journal of the Movement Disorder Society 39 (2) (2023)
Alberto J Espay, Robert A Hauser, Rohit Dhall, Sandeep Thakkar, Leslie Cloud, Leonid Zeitlin, Ghazal Banisadr, Stanley Fisher, Hester Visser
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study. Movement disorders : official journal of the Movement Disorder Society (2023)
Davide Martino, Vikram Karnik, Roongroj Bhidayasiri, Deborah A Hall, Robert A Hauser, Antonella Macerollo, Tamara M Pringsheim, Daniel Truong, Stewart A Factor, Matej Skorvanek, Anette-Eleonore Schrag, null null
Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. Movement disorders : official journal of the Movement Disorder Society (2023)
Robert A Hauser, Nir Giladi, Werner Poewe, Jonathan Brotchie, Hadas Friedman, Sheila Oren, Pninit Litman
P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's Disease. Advances in therapy 39 (5) (2022)
Robert A Hauser, Antonella Favit, L Arthur Hewitt, Annika Lindsten, Stephen Gorny, Steven Kymes, Stuart H Isaacson
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment. Neurology and therapy 11 (1) (2022)
Gareth Morinan, Robert A Hauser, Anette-Eleonore Schrag, Jingxuan Tang, Jonathan O'Keeffe, null Mds-Nms Scale Development Study Group
Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search. Parkinson's disease 2022 (2022)
Michael Camilleri, Thyagarajan Subramanian, Fernando Pagan, Stuart H Isaacson, Ramon Gil, Robert A Hauser, Mary Feldman, Mark Goldstein, Rajeev Kumar, Daniel Truong, Nisha Chhabria, Benjamin L Walter, Jonathan Eskenazi, Robert Riesenberg, Daniel Burdick, Winona Tse, Eric Molho, Bradley Robottom, Perminder Bhatia, Srinath Kadimi, Kevin Klos, David R Shprecher, Otto Marquez-Mendoza, Gonzalo Hidalgo, Stephen Grill, George Li, Howard Mandell, Mary Hughes, Sharisse Stephenson, Joel Vandersluis, Michael Pfeffer, Andrew Duker, Vikram Shivkumar, William Kinney, James MacDougall, Michael Zasloff, Denise Barbut
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial. Annals of internal medicine (2022)
Robert A Hauser, Judy Lytle, Andrea E Formella, Caroline M Tanner
Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson's disease. NPJ Parkinson's disease 8 (1) (2022)
Tamara Pringsheim, Gregory S Day, Don B Smith, Alex Rae-Grant, Nicole Licking, Melissa J Armstrong, Rob M A de Bie, Emmanuel Roze, Janis M Miyasaki, Robert A Hauser, Alberto J Espay, Justin P Martello, Julie A Gurwell, Lori Billinghurst, Kelly Sullivan, Michael S Fitts, Nicholas Cothros, Deborah A Hall, Miriam Rafferty, Lynn Hagerbrant, Tara Hastings, Mary Dolan O'Brien, Heather Silsbee, Gary Gronseth, Anthony E Lang, null null
Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology 97 (20) (2022)
Anna Naito, Anne-Marie Wills, Thomas Francis Tropea, Adolfo Ramirez-Zamora, Robert A Hauser, Davide Martino, Travis H Turner, Miriam R Rafferty, Mitra Afshari, Karen L Williams, Okeanis E Vaou, Martin J McKeown, Letty Ginsburg, Adi Ezra, Robert Iansek, Kristin Wallock, Christiana Evers, Karlin Schroeder, Rebeca DeLeon, Nicole Yarab, Roy N Alcalay, James C Beck
Expediting telehealth use in clinical research studies: recommendations for overcoming barriers in North America. NPJ Parkinson's disease 7 (1) (2021)
Aleksandar Videnovic, Amy W Amara, Cynthia Comella, Paula K Schweitzer, Helene Emsellem, Kris Liu, Amanda L Sterkel, Mildred D Gottwald, Joshua R Steinerman, Philip Jochelson, Katie Zomorodi, Robert A Hauser
Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial. Movement disorders : official journal of the Movement Disorder Society 36 (10) (2021)
Robert A Hauser, Ghazal Banisadr, Kara Vuong, David Freilich, Stanley Fisher, Richard D'Souza
Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary®): Results of a Nationwide Dose Conversion Survey. Parkinson's disease 2021 (2021)
Robert A Hauser, Jonathan M Meyer, Stewart A Factor, Cynthia L Comella, Caroline M Tanner, Rose Mary Xavier, Stanley N Caroff, Leslie Lundt
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice. CNS spectrums (2020)